α1-アンチトリプシン(AAT)欠乏症増強療法の世界市場:規模・現状・予測

QYResearchが発行した調査報告書(DATA909X18150)
◆英語タイトル:Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, Status and Forecast 2019-2025
◆商品コード:DATA909X18150
◆発行会社(リサーチ会社):QYResearch
◆発行日:2019年11月25日(※2024年版があります。お問い合わせください)
◆ページ数:96
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※当調査レポートでは、α1-アンチトリプシン(AAT)欠乏症増強療法の世界市場について調査・分析し、α1-アンチトリプシン(AAT)欠乏症増強療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別(グラッシア、アララストNP、プロラスチンC、その他)、用途別(病院、専門クリニック)、地域別(北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米)に区分して市場規模を算出しました。


・レポートの概要
・世界のα1-アンチトリプシン(AAT)欠乏症増強療法市場動向
・主要企業別マーケットシェア
・α1-アンチトリプシン(AAT)欠乏症増強療法の種類別市場規模2014-2019
(グラッシア、アララストNP、プロラスチンC、その他)
・α1-アンチトリプシン(AAT)欠乏症増強療法の用途別市場規模2014-2019
(病院、専門クリニック)
・α1-アンチトリプシン(AAT)欠乏症増強療法の北米市場:主要企業・種類別/用途別市場規模
・α1-アンチトリプシン(AAT)欠乏症増強療法のヨーロッパ市場:主要企業・種類別/用途別市場規模
・α1-アンチトリプシン(AAT)欠乏症増強療法の中国市場:主要企業・種類別/用途別市場規模
・α1-アンチトリプシン(AAT)欠乏症増強療法の日本国内市場:主要企業・種類別/用途別市場規模
・α1-アンチトリプシン(AAT)欠乏症増強療法の東南アジア市場:主要企業・種類別/用途別市場規模
・α1-アンチトリプシン(AAT)欠乏症増強療法のインド市場:主要企業・種類別/用途別市場規模
・α1-アンチトリプシン(AAT)欠乏症増強療法の中南米市場:主要企業・種類別/用途別市場規模
・主要企業のプロフィール
(Grifols、CSL、Baxter、Kamada、Takeda、Abeona)
・α1-アンチトリプシン(AAT)欠乏症増強療法の市場規模予測2019-2025
(種類別、用途別、地域別市場予測)
・アナリストの観点・結論
...
【レポートの概要】

Alpha-1 antitrypsin deficiency (AATD) is an inherited condition characterized as a low or unpredictable level of alpha-1 protein, generated by liver. The disease most commonly affects lungs and liver and is often undiagnosed. Augmentation therapy is the most specific therapy for the treatment of AATD, and includes various preparations derived from pooled human plasma.In 2018, the global Alpha-1 Antitrypsin Deficiency Augmentation Therapy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Alpha-1 Antitrypsin Deficiency Augmentation Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Alpha-1 Antitrypsin Deficiency Augmentation Therapy development in North America, Europe and Asia-Pacific.

The key players covered in this study
Grifols
CSL
Baxter
Kamada
Takeda
Abeona

Market segment by Type, the product can be split into
Glassia
Aralast NP
Prolastin C
Others

Market segment by Application, split into
Hospitals
Specialty Clinics

Market segment by Regions/Countries, this report covers
North America
Europe
Asia-Pacific

The study objectives of this report are:
To analyze global Alpha-1 Antitrypsin Deficiency Augmentation Therapy status, future forecast, growth opportunity, key market and key players.
To present the Alpha-1 Antitrypsin Deficiency Augmentation Therapy development in North America, Europe and Asia-Pacific.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Alpha-1 Antitrypsin Deficiency Augmentation Therapy are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Growth Rate by Type (2014-2025)
1.4.2 Glassia
1.4.3 Aralast NP
1.4.4 Prolastin C
1.4.5 Others
1.5 Market by Application
1.5.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Application (2019-2025)
1.5.2 Hospitals
1.5.3 Specialty Clinics
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size
2.2 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Growth Trends by Regions
2.2.1 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Regions (2019-2025)
2.2.2 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by by Players
3.1.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue by by Players (2014-2019)
3.1.2 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share by by Players (2014-2019)
3.1.3 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Concentration Ratio (CR5 and HHI)
3.2 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Key Players Head office and Area Served
3.3 Key Players Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product/Solution/Service
3.4 Date of Enter into Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2014-2019)
4.2 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2014-2019)

5 North America
5.1 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (2014-2019)
5.2 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Key Players in North America
5.3 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type
5.4 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application

6 Europe
6.1 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (2014-2019)
6.2 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Key Players in Europe
6.3 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type
6.4 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application

7 Asia-Pacific
7.1 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (2014-2019)
7.2 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Key Players in Asia-Pacific
7.3 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type
7.4 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application

8 International Players Profiles
8.1 Grifols
8.1.1 Grifols Company Details
8.1.2 Company Description and Business Overview
8.1.3 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
8.1.4 Grifols Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2014-2019))
8.1.5 Grifols Recent Development
8.2 CSL
8.2.1 CSL Company Details
8.2.2 Company Description and Business Overview
8.2.3 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
8.2.4 CSL Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2014-2019)
8.2.5 CSL Recent Development
8.3 Baxter
8.3.1 Baxter Company Details
8.3.2 Company Description and Business Overview
8.3.3 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
8.3.4 Baxter Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2014-2019)
8.3.5 Baxter Recent Development
8.4 Kamada
8.4.1 Kamada Company Details
8.4.2 Company Description and Business Overview
8.4.3 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
8.4.4 Kamada Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2014-2019)
8.4.5 Kamada Recent Development
8.5 Takeda
8.5.1 Takeda Company Details
8.5.2 Company Description and Business Overview
8.5.3 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
8.5.4 Takeda Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2014-2019)
8.5.5 Takeda Recent Development
8.6 Abeona
8.6.1 Abeona Company Details
8.6.2 Company Description and Business Overview
8.6.3 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
8.6.4 Abeona Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2014-2019)
8.6.5 Abeona Recent Development

9 Market Forecast 2019-2025
9.1 Market Size Forecast by Product (2019-2025)
9.2 Market Size Forecast by Application (2019-2025)
9.3 Market Size Forecast by Regions
9.4 North America
9.5 Europe
9.6 Asia-Pacific

10 Analyst’s Viewpoints/Conclusions

11 Appendix
11.1 Research Methodology
11.1.1 Methodology/Research Approach
11.1.1.1 Research Programs/Design
11.1.1.2 Market Size Estimation
11.1.1.3 Market Breakdown and Data Triangulation
11.1.2 Data Source
11.1.2.1 Secondary Sources
11.1.2.2 Primary Sources
11.2 Disclaimer
11.3 Author Details

List of Tables and Figures

Table Alpha-1 Antitrypsin Deficiency Augmentation Therapy Key Market Segments
Table Key Players Alpha-1 Antitrypsin Deficiency Augmentation Therapy Covered
Table Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Glassia Figures
Table Key Players of Glassia
Figuer Aralast NP Figures
Table Key Players of Aralast NP
Figuer Prolastin C Figures
Table Key Players of Prolastin C
Figuer Others Figures
Table Key Players of Others
Table Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Application in 2018 & 2025
Figure Hospitals Case Studies
Figure Specialty Clinics Case Studies
Figure Alpha-1 Antitrypsin Deficiency Augmentation Therapy Report Years Considered
Figure Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Regions 2019-2025 (Million US$)
Table Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Regions 2019-2025 (Million US$)
Table Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Regions 2014-2019
Figure Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Regions 2014-2019
Figure Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue by by Players (2014-2019) (Million US$)
Table Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by by Players (2014-2019)
Figure Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by by Players in 2018
Table Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product/Solution/Service
Table Date of Enter into Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2014-2019) (Million US$)
Table Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Share by Type (2014-2019)
Figure Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Market Share by Type (2014-2019)
Table Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2014-2019) (Million US$)
Table Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Share by Application (2014-2019)
Figure Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Market Share by Application (2014-2019)
Figure Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share by Application in 2018
Figure North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size 2014-2019 (Million US$)
Table North America Key Players Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue (2018-2019) (Million US$)
Table North America Key Players Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share (2018-2019)
Table North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type 2014-2019 (Million US$)
Table North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Type 2014-2019
Table North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application 2014-2019 (Million US$)
Table North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Application 2014-2019
Figure Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size 2014-2019 (Million US$)
Table Europe Key Players Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue (2018-2019) (Million US$)
Table Europe Key Players Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share (2018-2019)
Table Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type 2014-2019 (Million US$)
Table Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Type 2014-2019
Table Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application 2014-2019 (Million US$)
Table Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Application 2014-2019
Figure Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size 2014-2019 (Million US$)
Table Asia-Pacific Key Players Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue (2018-2019) (Million US$)
Table Asia-Pacific Key Players Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share (2018-2019)
Table Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type 2014-2019 (Million US$)
Table Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Type 2014-2019
Table Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application 2014-2019 (Million US$)
Table Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Application 2014-2019
Table Grifols Company Details
Table Grifols Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business 2014-2019 (Million US$)
Figure Grifols Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2014-2019)
Table Grifols Recent Development
Table CSL Company Details
Table CSL Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business 2014-2019 (Million US$)
Figure CSL Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2014-2019)
Table CSL Recent Development
Table Baxter Company Details
Table Baxter Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business 2014-2019 (Million US$)
Figure Baxter Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2014-2019)
Table Baxter Recent Development
Table Kamada Company Details
Table Kamada Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business 2014-2019 (Million US$)
Figure Kamada Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2014-2019)
Table Kamada Recent Development
Table Takeda Company Details
Table Takeda Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business 2014-2019 (Million US$)
Figure Takeda Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2014-2019)
Table Takeda Recent Development
Table Abeona Company Details
Table Abeona Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business 2014-2019 (Million US$)
Figure Abeona Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2014-2019)
Table Abeona Recent Development
Table Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Regions (Million US$) 2019-2025
Figure Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Share by Regions (2019-2025)
Figure Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Share by Regions in 2025
Figure North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Forecast (2019-2025)(Million USD)
Figure Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Forecast (2019-2025)(Million USD)
Figure Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Forecast (2019-2025)(Million USD)
Table Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Product (2019-2025) (Million US$)
Figure Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Product (2019-2025)
Figure Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Product in 2025
Table Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2019-2025) (Million US$)
Figure Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2019-2025)
Figure Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Grifols、CSL、Baxter、Kamada、Takeda、Abeona

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ α1-アンチトリプシン(AAT)欠乏症増強療法の世界市場:規模・現状・予測(Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, Status and Forecast 2019-2025)]についてメールでお問い合わせはこちらでお願いします。